Posilac® has impact on carbon footprint reduction.

This episode is sponsored by Union Agener.

About Union Agener:

The plant was acquired in October 2018 by Fernando de Castro Marques, a majority shareholder of União Química, one of the largest groups in the pharmaceutical industry in Brazil. “Now we are in full control of operations and we will begin production of new Posilac® batches to fully satisfy the demands of the American market and other export markets,” says Fernando de Castro Marques, president of Union Agener and Grupo União Química Farmacêutica. The product is marketed globally under the trademarks Posilac® and Lactotropin.

This factory complex is FDA certified, having the product present in 22 countries, including the USA.